Glycogen synthase downregulation rescues the amylopectinosis of murine RBCK1 deficiency
Silvia Nitschke(The University of Texas Southwestern Medical Center), Berge A. Minassian(Southwestern Medical Center)
Cited by 25
Related Papers
Inhibiting glycogen synthesis prevents lafora disease in a mouse model
|Annals of Neurology|2013|111
Complete loss of the DNAJB6 G/F domain and novel missense mutations cause distal-onset DNAJB6 myopathy
|Acta Neuropathologica Communications|2015|60
<i>Gys1</i> antisense therapy rescues neuropathological bases of murine Lafora disease
|Brain|2021|51
Nationwide genetic testing towards eliminating Lafora disease from Miniature Wirehaired Dachshunds in the United Kingdom
|Canine Genetics and Epidemiology|2018|17
Laforin targets malin to glycogen in Lafora progressive myoclonus epilepsy
|Disease Models & Mechanisms|2022|16